日本肝臓学会の公式アカウントです。学会からのお知らせを情報発信します。 Official account of the Japan Society of Hepatology
Tokyo, Japan
Joined August 2020
- Tweets1.7K
- Following54
- Followers2.7K
- Likes2.7K
日本肝臓学会 retweeted
#Steatohepatitis
▶️Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease
👉doi.org/10.1111/hepr.70224
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Autoimmune
▶️Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study
👉doi.org/10.1111/hepr.70223
#LiverX @WileyHealth
日本肝臓学会 retweeted
#LiverCancer
▶️Fragmentation Analysis of the MYC Enhancer in Cell-Free DNA by qPCR for Early Detection of Hepatocellular Carcinoma
👉doi.org/10.1111/hepr.70222
#LiverX @WileyHealth
日本肝臓学会 retweeted
【JDDW2026大会長による「選べるJDDWの歩き方」】
肝移植の最新動向を丸ごと学ぶか、進歩する肝がん診療をキャッチアップするか。第62回日本肝臓学会大会長 波多野悦朗氏がおすすめするJDDWの歩き方、あなたはどちらを選ぶ？
■コース詳細はこちら→x.gd/Fyogc
@jsge1898
@jges1959
@JSHLiver
@JSGS_official
@JSGCS1959
#JDDW #JDDW2026
日本肝臓学会 retweeted
#Steatohepatitis
▶️Hepatic Steatosis Detected by Abdominal Ultrasonography Is Associated With Worse Prognosis in Underweight Patients
👉doi.org/10.1111/hepr.70220
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Cirrhosis
▶️Lipopolysaccharide Binding Protein and Soluble Mannose Receptor as Biomarkers for Acute Kidney Injury in Cirrhosis
👉doi.org/10.1111/hepr.70217
#LiverX @WileyHealth
日本肝臓学会 retweeted
📌School of Hepatology開催報告
10/11-12に「 #MASLD を極める」と題して開催されました。
とても学びのある会となりました。
参加者の皆様、ご講演いただいた先生方、そして当教室スタッフに感謝です。
また皆様にお会いできますように✨
@JSHLiver
@NANALv_YCU
@nogamia_liver
日本肝臓学会 retweeted
#LiverCancer
▶️Tumor Endothelial Cell-Derived Extracellular Vesicles Promote Hepatocellular Carcinoma Progression Through Intercellular Interaction Via miRNA
👉doi.org/10.1111/hepr.70216
#LiverX @WileyHealth
日本肝臓学会 retweeted
#LiverCancer
▶️Low Alpha-Fetoprotein in Non-Viral Early-Stage Hepatocellular Carcinoma: Complementary Des-Gamma-Carboxyprothrombin
👉doi.org/10.1111/hepr.70215
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Steatohepatitis
▶️Toward a Synthetic Data Revolution: Diffusion Model-Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease
👉doi.org/10.1111/hepr.70213
#LiverX @WileyHealth
日本肝臓学会 retweeted
MT読者の人気投票で決まる当地のグルメ企画「気分とシーンで選ぶ神戸グルメ」を公開！ 一人でサクッと食べたいとき、大切な恩師や上司の接待などお店選びの参考にしては？
今年の神戸グルメをチェック！→x.gd/osn8i
@jsge1898 @jges1959 @JSHLiver @JSGS_official @JSGCS1959
#JDDW #JDDW2026
日本肝臓学会 retweeted
#ViralHepatitis
▶️Hepatitis B Virus Infection Status in Japanese Children Prior to Universal Vaccination: Sustained Effectiveness of Mother-to-Child Transmission Prevention and Residual Infection Burden
👉doi.org/10.1111/hepr.70212
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Autoimmune
▶️Anti-Integrin αvβ6 Autoantibodies as Diagnostic and Monitoring Biomarkers for Pediatric-Onset Primary Sclerosing Cholangitis
👉doi.org/10.1111/hepr.70211
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Letter
▶️Variability in Liver Disease Progression and Outcomes in Glycogen Storage Disease Type IV
👉doi.org/10.1111/hepr.70201
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Letter
▶️Comment on“Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray”
👉doi.org/10.1111/hepr.70199
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Letter
▶️Letter to the Editor: “Surgical Resections for Hepatocellular Carcinomas Arising From Fontan-Associated Liver Disease; Open, Laparoscopic and Robotic Hepatectomies”
👉doi.org/10.1111/hepr.70192
#LiverX @WileyHealth
日本肝臓学会 retweeted
#LiverCancer
▶️Compensatory Hepatic Hypertrophy After Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Factors Associated With Its Development and Relationship With Prognosis
👉doi.org/10.1111/hepr.70206
#LiverX @WileyHealth
日本肝臓学会 retweeted
#ShortCommunication
▶️ALDH2 Polymorphism in Alcohol-Related Cirrhosis Requiring Liver Transplantation: A Recipient–Donor Analysis
👉doi.org/10.1111/hepr.70200
#LiverX @WileyHealth
日本肝臓学会 retweeted
#Fibrosis
▶️FOXS1 Promotes Liver Fibrosis Through TGF-β1/Smad Signaling: Targeting a Novel miR-212-5p/FTO Axis
👉doi.org/10.1111/hepr.70208
#LiverX @WileyHealth
